Skip to main content

Table 1 Pulmonary function tests

From: The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature

Spirometry

FEV1

2.47 L

(80 % predicted)

FVC

3.37 L

(94 % predicted)

FEV1/FVC

73.44 %

 

Transfer factors

TLCO

70 % predicted

 

KCO

85 % predicted

 

Body plethysmography

TLC

5.24 L

(97 % predicted)

VC

3.39 L

(93 % predicted)

  1. Pulmonary function tests performed seven days ante mortem, including lung volumes and transfer factors, were unremarkable
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us